BioSpace News Archive

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a broad pipeline which includes checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced the expansion of a Phase 2 trial into colon cancer based on a new objective clinical response in a colorectal cancer patient in addition to a significant tumor reduction of 27% and biomarker reduction observed i

AbbVie (NYSE: ABBV) will host a virtual immunology strategic update for investors on Monday, December 14, 2020 at 9:00 a.m. Central time. Richard A. Gonzalez, chairman of the board and chief executive officer, and members of the executive leadership team will present on AbbVie’s immunology business and pipeline.

NeuroTherapia, Inc., a clinical-stage company focused on developing therapies for neurodegenerative diseases, announced today the completion of its first-in-human study of NTRX-07.

CSafe Global continues to focus on innovating temperature-controlled container solutions with the launch of 24/7 real-time shipment visibility.

Health Decisions, Inc. and OncoBay Clinical, Inc. announced a partnership to deliver specialized clinical development services for pharmaceutical and biotechnology companies developing therapeutics, medical devices, and diagnostics in oncology.

I-Mab (the “Company”) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced the strengthening of its Scientific Advisory Board (“SAB”) with the appointment of leading international experts Dr. Chen Dong and Dr.

BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced two new co-investments with innovation accelerator partner Casdin Capital.

Biovo Technologies Ltd. (“Biovo”) (WSE: AWM), a medical device company focused on devices for Critical Care and Operating Rooms, announced today it has signed exclusive distribution agreements for B-Care Oral Care in Australia , Br

Vesigen Therapeutics, Inc., a biotechnology company pioneering a novel extracellular vesicle delivery technology to develop transformative therapeutics, today announced the addition of Dr. Lucio Iannone, Senior Director of Venture Investments at Leaps by Bayer, to its Board of Directors.

Thermo Scientific Neoma Multicollector ICP-MS extracts reliable isotopic data from even the smallest samples, with new levels of sensitivity, accuracy and productivity